Skip to content

Other Financing at other companies

Medtronic logo
MedtronicMDT
$70M+567%
STERIS logo
STERISSTE
$600K-90.2%
ITG
Integer HoldingsITGR
-$106K-251%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$2.14M+4,019%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$0-100%
Henry Schein logo
Henry ScheinHSIC
$0-100%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's other financing?
Integra LifeSciences (IART) reported other financing of $0 in Q1 2026.
How has Integra LifeSciences's other financing changed year-over-year?
Integra LifeSciences's other financing decreased by 100.0% year-over-year, from $2.6M to $0.
What does other financing mean?
Miscellaneous financing cash flows not classified in specific line items.